.jpg?auto=webp&fit=crop&height=675&width=1200#)
GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales. The post GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion appeared first on Investor's Business Daily.
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 billion in sales.
The post GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
